Measles: Clinical Trials

125 trials for Measles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

89 completed, 19 unknown, 6 not yet recruiting, 5 recruiting. 43 Phase 3, 23 Phase 4, 18 Phase 2, 17 Not applicable, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 343Completed 36, Unknown 3, Not yet recruiting 2, Recruiting 1, Terminated 1
Phase 423Completed 17, Unknown 4, Recruiting 2
Phase 218Completed 14, Unknown 3, Terminated 1
Not applicable17Completed 10, Unknown 5, Active not recruiting 1, Not yet recruiting 1
Phase 15Completed 3, Terminated 1, Unknown 1

Follow Measles: new trials by email Literature Review of Measles trials Research Report on Measles

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age
MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps
Phase 3Not yet recruitingGlaxoSmithKline18602026-08-112026-08-03
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age
MMRVNS, MMRV - Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Phase 3RecruitingGlaxoSmithKline12092026-05-112026-07-08
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
Polio, Measles
Not yet recruitingChina National Biotec Group Company Limited6002026-01-302026-01-14
The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency
Iron syrup, Multivitamin syrup, R21-Matrix/M Vaccine (malaria vaccine) - Iron Deficiencies
Not applicableNot yet recruitingNicole Stoffel3242026-01-052025-12-26
Unravelling the Measles Paradox in Children
MEASLES DISEASE
Not yet recruitingErasmus Medical Center1002026-01-032025-11-26
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
Commercial measles, mumps, and rubella (MMR) vaccine - Heart Transplant Infection Prevention
Phase 4RecruitingChildren's Mercy Hospital Kansas City602025-09-112026-09-24
Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections
Exanthema, Dengue Fever
Not yet recruitingHospital Israelita Albert Einstein8302025-09-012025-08-08
Clinical Diagnostic Performance Evaluation of a Measles Rapid Test in Senegal
Measles rapid diagnostic test - Measles
TerminatedInstitut Pasteur de Dakar2542025-08-222026-09-02
Unravelling the Measles Paradox (MISIA)
MEASLES DISEASE
RecruitingErasmus Medical Center3002025-07-032025-12-05
Predictors of Measles Vaccine Hesitancy in New York State
Survey - Measles Vaccination
CompletedAlbany Medical College992025-07-012026-01-28
Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months
Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd, Yellow fever Vaccine (WHO prequalified) - Measles, Rubella
Phase 3Not yet recruitingInternational Centre for Diarrhoeal Disease Research, Bangladesh15302025-04-012025-02-07
Barriers and Facilitators to MMR Vaccination Among Healthcare Workers
MMR vaccination - Measles
CompletedKing's College London232024-09-122025-05-06
Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months
SIBP MMR Vaccine, GSK MMR Vaccine (PRIORIX), Yellow Fever Vaccine (Stamaril) - Measles-Mumps-Rubella
Phase 3CompletedShanghai Institute Of Biological Products12002024-06-282026-01-08
Increasing Measles Vaccination Coverage Through Supplementation With an SQ-LNS Incentive in Children Aged 6-23 Months
Small-quantity lipid-based nutrition supplements (SQ-LNS) NutriVax, Sensitization on vaccination and on Infant and Young Child Feeding (IYCF) practices - Immunization Coverage, Vaccination
Not applicableCompletedAlliance for International Medical Action38142024-05-072026-07-31
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)
Vero cell-drived inactive Japanese encephalitis vaccine, Measles-Mumps-Rubella Vaccine - Japanese Encephalitis, Measles
Phase 4CompletedLiaoning Chengda Biotechnology CO., LTD4082024-03-022025-08-28
A Tool Kit to Improve Vaccine Confidence in the Philippines
Educational toolkit on MMR and polio vaccination - Measles, Polio
Not applicableActive not recruitingUniversity of Toronto54002024-01-312025-03-11
Role of Ketogenic Diet in SSPE
KETOGENIC DIET - SSPE
Not applicableUnknownAga Khan University262024-01-012023-07-25
Immunity in Persons Fully Vaccinated Against Measles, Mumps and Rubella and Responses to Booster Vaccination
MMR booster vaccination (as M-M-R-VaxPro) - Mumps, Measles
Phase 3UnknownUniversity of Zurich2002023-12-012024-01-08
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
Licenced Measles-Rubella vaccine - Measles
Phase 2UnknownUniversity of Oxford4502023-11-152024-10-31

Showing 20 of 125. Sign in to see all of them.

Narrower conditions

Rubella (81)  ·  Mumps (71)  ·  Chickenpox (45)  ·  Tetanus (9)  ·  Whooping Cough (9)  ·  Haemophilus Infections (8)  ·  Diphtheria (7)  ·  Poliomyelitis (7)  ·  Hepatitis B (6)  ·  Encephalitis, Japanese (5)  ·  Hepatitis A (5)  ·  Chikungunya Fever (3)  ·  HIV Infections (3)  ·  Infant Death (3)

Broader conditions

Infections (125)  ·  Mononegavirales Infections (125)  ·  Morbillivirus Infections (125)  ·  Paramyxoviridae Infections (125)  ·  RNA Virus Infections (125)  ·  Virus Diseases (124)  ·  Togaviridae Infections (82)  ·  Rubivirus Infections (81)  ·  Mouth Diseases (71)  ·  Parotid Diseases (71)  ·  Parotitis (71)  ·  Rubulavirus Infections (71)  ·  Salivary Gland Diseases (71)  ·  Stomatognathic Diseases (71)  ·  DNA Virus Infections (51)

Interventions

measles, mumps, rubella, varicella vaccine (23)  ·  Measles-Mumps-Rubella Vaccine (20)  ·  Chickenpox Vaccine (11)  ·  Measles Vaccine (10)  ·  Hepatitis A Vaccines (8)  ·  Rubella Vaccine (8)  ·  Heptavalent Pneumococcal Conjugate Vaccine (5)  ·  Vaccines (4)  ·  13-valent pneumococcal vaccine (3)  ·  Meningococcal Vaccines (3)  ·  Priorix-Tetra vaccine (3)  ·  Vaccines, Attenuated (3)  ·  CRM197 (non-toxic variant of diphtheria toxin) (2)  ·  DTPP vaccine (2)  ·  Pneumococcal Vaccines (2)

Sponsors

GlaxoSmithKline (23)  ·  Merck Sharp & Dohme LLC (19)  ·  Bandim Health Project (7)  ·  Sanofi Pasteur, a Sanofi Company (6)  ·  The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Centers for Disease Control and Prevention (3)  ·  Johns Hopkins Bloomberg School of Public Health (3)  ·  Centers for Disease Control and Prevention, China (2)  ·  Erasmus Medical Center (2)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (2)  ·  Takeda (2)  ·  Aga Khan University (1)  ·  Albany Medical College (1)  ·  Alliance for International Medical Action (1)

Countries

United States (27)  ·  Puerto Rico (10)  ·  China (8)  ·  Germany (8)  ·  Guinea-Bissau (7)  ·  Brazil (6)  ·  Italy (6)  ·  Taiwan (6)  ·  Finland (5)  ·  France (5)  ·  Estonia (3)  ·  Netherlands (3)  ·  Nigeria (3)  ·  Thailand (3)  ·  Bangladesh (2)

Top investigators

Alison Connor (1)  ·  Alison Connor, PhD (1)  ·  Amanda Dempsey, MD, PhD, MPH (1)  ·  Anne Fiquet, MD (1)  ·  Carl T. D'Angio, MD (1)  ·  Carolyn B Moore, MD (1)  ·  Chandwani S (1)

Results publications

PMID 32813276, PMID 10342702, PMID 11228365, PMID 11672911, PMID 12443658, PMID 12798618, PMID 14506371, PMID 15082642, PMID 15626943, PMID 15659474, PMID 16094218, PMID 16452343, PMID 16567978, PMID 16804432, PMID 17060336, PMID 17332177, PMID 17502347, PMID 17938165, PMID 18653640, PMID 19305145, PMID 19366435, PMID 19663708, PMID 19712484, PMID 19923206, PMID 20955461, PMID 21118875, PMID 21666159, PMID 22123890, PMID 22406278, PMID 22693229, PMID 22772170, PMID 23043671, PMID 23994379, PMID 24436454, PMID 24688075, PMID 24829213, PMID 24835247, PMID 25131735, PMID 25149833, PMID 25232151, PMID 25765966, PMID 26362659, PMID 27149048, PMID 27423382, PMID 27466046, PMID 27879555, PMID 27912735, PMID 28288747, PMID 28481690, PMID 28992261

NIH funding

2025 (2), 2014 (1), R01AI070018 (1)